TissueTinker Bio. - News

TissueTinker Bio.

TissueTinker News

Follow us on LinkedIn for our latest updates

Recent Articles

Can 3D printers help find a cure for cancer?

Beyond the Petri Dish: TissueTinker’s Next-Generation Tumour Models

TissueTinker’s bioprinted tumors offer new cancer drug testing modelSecure your spot now for exclusive AM insights at our Additive Manufacturing Advantage online conference covering aerospace, space, and defense! McGill University’s spinout TissueTinker is exploring a

TissueTinker explores 3D printed cures for cancerTissueTinker explores 3D printed cures for cancer. The McGill University startup creates miniaturized tumour models.

En hommage au legs entrepreneurial de Pierre Péladeau, qui aurait célébré son 100e anniversaire en 2025, AsterX Québecor est fière de présenter la première édition de son palmarès annuel des start-ups les plus prometteuses issues des bancs universitaires d’ici. Pour cette nouvelle génération de jeunes visionnaires, l’avenir est 100 limite!

Learn how the world of preclinical drug development is changing

In Landmark Shift, NIH Announces It Will No Longer Solicit Animal-Only ResearchWashington, D.C. – In a historic move, the U.S. National Institutes of Health (NIH) announced today that it will no longer seek research proposals exclusively for projects involving animals.

FDA Modernization Act 2.0 allows for alternatives to animal testing - PubMedOn December 29, 2022, President Biden signed into law the FDA Modernization Act 2.0. The bill essentially refutes the Federal Food, Drug, and Cosmetics Act of 1938, which mandated animal testing for every new drug development protocol. While for the past century, the mandate was intended to ensure c …

FDA Announces Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other DrugsFDA Plans to Phase Out Animal Testing Requirement

Page updated

Google Sites

Report abuse